In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

Kidney failure, also known as end-stage renal disease (ESRD), occurs when kidneys lose their ability to filter waste and excess fluids from the blood effectively. This serious condition affects ...

Discover how a traditional Chinese herbal mix showed better results in treating a common kidney disease compared to commonly ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...

Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...